St. Franziskus Hospital Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2007
NCT00803816
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Carsten Heinz | Department of Ophthalmology at St. Franziskus Hospital | St. Franziskus Hospital | St. Franziskus Hospital, Cologne and Bonn Education Association for Dietetics r.A., Cologne, Germany

Active Ingredients

Drugs in Phase 2 Trials (1)

everolimus (zortress) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Uveitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1